# Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

> **NCT07314307** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Karolinska Institutet** · enrollment: 150000 (estimated)

## Conditions studied

- Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection

## Interventions

- **BIOLOGICAL:** Gardasil 9 2 dose regimen

## Key facts

- **NCT ID:** NCT07314307
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-03
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 150000 (ESTIMATED)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314307, "Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07314307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*